Signet Investment Advisory Group, Inc. Eli Lilly & CO Transaction History

Signet Investment Advisory Group, Inc.

$200 Million
Q3 2024

A detailed history of Signet Investment Advisory Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Signet Investment Advisory Group, Inc. holds 3,819 shares of LLY stock, worth $3.47 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

3,819

Previous 7,434 48.63%

Holding current value

$3.47 Million

Previous $6.73 Million 49.73%

% of portfolio

1.69%

Previous 3.61%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$772.14 - $960.02 $2.79 Million - $3.47 Million	-3,615 Reduced 48.63%	3,819 $3.38 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $28,994 - $36,361	-40 Reduced 0.54%	7,434 $6.73 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $106,596 - $142,610	-180 Reduced 2.35%	7,474 $5.81 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $42,540 - $50,149	-81 Reduced 1.05%	7,654 $4.46 Million
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $66,074 - $91,093	-152 Reduced 1.93%	7,735 $4.15 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $148,363 - $198,378	-423 Reduced 5.09%	7,887 $3.7 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $46,905 - $55,087	-151 Reduced 1.78%	8,310 $2.85 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $144,697 - $168,601	-450 Reduced 5.05%	8,461 $0
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $221,767 - $252,726	-748 Reduced 7.74%	8,911 $2.88 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $218,524 - $256,579	-784 Reduced 7.51%	9,659 $3.13 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $434,645 - $540,154	-1,852 Reduced 15.06%	10,443 $2.99 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $36,650 - $45,483	-163 Reduced 1.31%	12,295 $3.4 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $111,243 - $136,900	-502 Reduced 3.87%	12,458 $2.88 Million
Q2 2021 Jul 26, 2021	SELL	$180.55 - $233.54 $131,440 - $170,017	-728 Reduced 5.32%	12,960 $2.98 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $59,155 - $76,579	-360 Reduced 2.56%	13,688 $2.56 Million
Q4 2020 Feb 05, 2021	SELL	$130.46 - $172.63 $134,634 - $178,154	-1,032 Reduced 6.84%	14,048 $2.37 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $4,811 - $5,959	-45 Reduced 0.3%	15,080 $1.98 Million
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $13,348 - $14,520	-125 Reduced 0.82%	15,125 $1.69 Million
Q2 2019 Aug 06, 2019	SELL	$110.79 - $129.32 $29,802 - $34,787	-269 Reduced 1.73%	15,250 $1.69 Million
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $32,279 - $37,995	-290 Reduced 1.83%	15,519 $2.01 Million
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $1.67 Million - $1.88 Million	15,809 New	15,809 $1.83 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Investment Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Signet Investment Advisory Group, Inc. with notifications on news.

Account

Signet Investment Advisory Group, Inc. Eli Lilly & CO Transaction History